Overview | Index | DAIDS Home

The following links contain information regarding drug development resources for AIDS therapies available from other government agencies.

FDA -- Center for Drug Evaluation and Research (CDER)

Contains links to drug information and regulatory guidance regarding products regulated by this Center.

FDA -- New Drug Development and Review Process

This page within the CDER website provides information regarding new drug development, IND review, and NDA review.

FDA -- Pre-IND Consultation Program

This program is designed to facilitate informal early communications between FDA and potential sponsors of new therapeutics for the treatment of AIDS. Pre-IND advice may be requested for various drug development issues.

NIEHS -- AIDS Therapeutics Toxicity Studies Program

This National Institute of Environmental Health Sciences program collaborates with government agencies and pharmaceutical companies to evaluate in rodents the reproductive/developmental toxicity, general toxicity, immunotoxicity and neurotoxicity of AIDS therapeutics.